SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-21-001527
Filing Date
2021-02-19
Accepted
2021-02-19 15:44:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLULAR BIOMEDICINE GROUP, INC. p21-0773sc13da.htm SC 13D/A 236155
  Complete submission text file 0000902664-21-001527.txt   237555
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 100 ROCKVILLE MD 20850 (301) 825 5320
Cellular Biomedicine Group, Inc. (Subject) CIK: 0001378624 (see all company filings)

IRS No.: 861032927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-82437 | Film No.: 21655344
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 530 UNIVERSITY AVENUE, #17 PALO ALTO CA 94301
Business Address
Liu Tony (Filed by) CIK: 0001569983 (see all company filings)

Type: SC 13D/A